The 2026 European Association of Urology (EAU) annual meeting featured an advancing prognostics and therapeutics in metastatic prostate cancer session and a presentation by Dr. Rodrigo España Navarro ...

The 2026 European Association of Urology (EAU) annual meeting featured an advancements in metastatic castration resistant prostate cancer (mCRPC) therapy session and a presentation by Dr. Giulio ...

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

Cancer death rates in the UK have hit a record low, but the picture is more complicated than the headline figure suggests.

Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...

They use the body's own immune system to detect and kill cancer cells "Immunotherapies have been very promising and has ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...